Rubella Virus IgG Control Serum BC129G

$94.00

Summary

Virion/Serion Diagnostic Kit Control for research use (RUO)
Rubella Virus IgG Control Serum
Applications: ELISA
IgG control serum
Ready-to-use; pre-diluted for SERION ELISA classic and SERION ELISA antigen assays
3 mL

SKU: BC129G Categories: control serum, Virion/Serion kits Tags: ELISA control serum, IgG, Rubella Virus

Weight	1 lbs
Dimensions	9 × 5 × 2 in
target	Rubella Virus reactive IgG
species reactivity	Rubella Virus
applications	ELISA
assay type	Indirect & quantitative
available size	3 mL

Rubella Virus IgG Control Serum BC129G

kit
Research area Infectious Disease
Storage Store at 2-8°C.
Associated products Rubella Virus Avidity Reagent (B129AVID) Rubella Virus Grade 2 Antigen (BA129G2VS) Rubella Spike Ectodomain (E1-E2) Antigen (BA129R01) Rubella Virus IgG Control Serum (BC129G) Rubella Virus IgM Control Serum (BC129M) Rubella Virus IgG ELISA Kit (ESR129G) Rubella Virus IgM ELISA Kit (ESR129M)

target relevance

human antibody anti-Rubella Virus

Rubella Virus

Description
Virus that causes rubella (German measles) and congenital rubella syndrome

Structure
Rubella virus is an enveloped, positive-sense, single-stranded RNA virus belonging to the genus Rubivirus within the family Matonaviridae. Humans are the only known natural host of the virus. The viral particle contains an icosahedral nucleocapsid surrounded by a lipid envelope bearing glycoproteins that mediate host cell attachment and entry. Rubella virus is transmitted primarily through respiratory droplets and direct contact with respiratory secretions. Following infection, the virus replicates in the upper respiratory tract and regional lymphoid tissues before disseminating throughout the body. Although rubella infection is generally mild in children and adults, infection during pregnancy can result in transplacental transmission and severe fetal abnormalities known as congenital rubella syndrome (CRS). Widespread vaccination programs have dramatically reduced the incidence of rubella in many regions of the world.

Diagnosis
The diagnosis of rubella virus infection is performed through serological and molecular methods. Detection of rubella-specific IgM antibodies by ELISA is commonly used to diagnose recent infection, while measurement of IgG antibodies can determine immune status or previous exposure. IgG avidity testing may help distinguish recent primary infection from past infection or vaccination. Molecular methods such as reverse transcription polymerase chain reaction (RT-PCR) can detect viral RNA in respiratory specimens, blood, amniotic fluid, or other clinical samples and are particularly valuable in cases of congenital infection. Laboratory confirmation is especially important in pregnant women because of the significant risk of fetal complications associated with maternal infection.

Symptoms
Rubella virus infection typically develops following an incubation period of approximately fourteen to twenty-one days. The disease is often mild and may be asymptomatic, particularly in children. Common symptoms include low-grade fever, malaise, headache, lymphadenopathy, and a characteristic fine pink maculopapular rash that usually begins on the face and spreads to the trunk and extremities. Swelling of the posterior auricular, occipital, and cervical lymph nodes is a characteristic clinical feature. Adults, particularly women, may experience arthralgia or arthritis. The most serious consequence of rubella infection occurs during pregnancy, especially during the first trimester, when fetal infection can result in congenital rubella syndrome characterized by hearing impairment, cataracts, congenital heart defects, developmental delay, growth restriction, and fetal loss.

Data

FAQ & Publications

Frequently Asked Questions

What is the intended application for the Rubella Virus IgG Control Serum BC129G?

The Rubella Virus IgG Control Serum BC129G is designed for use in ELISA applications as an IgG control serum, specifically compatible with SERION ELISA classic and SERION ELISA antigen assays.

How should the Rubella Virus IgG Control Serum BC129G be stored to maintain its stability?

This control serum should be stored at 2-8°C to ensure its stability and effectiveness during use.

Is the Rubella Virus IgG Control Serum BC129G ready to use or does it require dilution?

The Rubella Virus IgG Control Serum BC129G is provided ready-to-use and pre-diluted for direct application in SERION ELISA assays.

What species does the Rubella Virus IgG Control Serum BC129G target for reactivity?

This control serum targets IgG antibodies reactive to Rubella Virus, which infects humans exclusively.

Publications

pmid	title	authors	citation
We haven't added any publications to our database yet.

Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from the PubMed database provided by the United States National Library of Medicine at the National Institutes of Health.

Protocols

relevant to this product
BC129G protocol

Documents

#
Please enter your product and batch number here.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Rubella Virus IgG Control Serum BC129G

Data

FAQ & Publications

Protocols

Documents

Related Technical Resources & Posts

Reviews

Related Products

Bordetella pertussis IgG Control Serum BC120G

Echovirus IgG Control Serum BC135G

Aspergillus fumigatus IgG Control Serum BC132G

Echinococcus IgG Control Serum BC107G

Adenovirus IgG Control Serum BC128G

Diphtheria IgG Control Serum BC130G

Human Toxoplasma gondii, rubella virus, cytomegalovirus (CMV), and herpes simplex virus type 1 and 2 (HSV-1/2) IgG Lateral flow dipstick kit 6472

Coxsackie IgG Virus Control Serum BC134G

ToRCH1/2 IgG Control Serum IC1701

Chlamydia trachomatis IgG Control Serum BC1372G

Chlamydia pneumoniae IgG Control Serum BC1371G

Candida albicans IgG Control Serum BC117G

Campylobacter jejuni IgG Control Serum BC139G

Brucella IgG Control Serum BC116G

Borrelia burgdorferi IgG Control Serum BC121G